Alzheimer’s Disease Clinical Trial
See if You Qualify Today
What is Alzheimer's Disease
Alzheimer’s disease is a progressive disease that destroys memory and other important mental functions.
It’s the most common cause of dementia — a group of brain disorders that results in the loss of intellectual and social skills. These changes are severe enough to interfere with day-to-day life.
It’s the most common cause of dementia — a group of brain disorders that results in the loss of intellectual and social skills. These changes are severe enough to interfere with day-to-day life.
In Alzheimer’s disease, the connections between brain cells and the brain cells themselves degenerate and die, causing a steady decline in memory and mental function.
Overview
If you suffer from Alzheimer’s disease or care for someone that does, then you know that memory loss is only one symptom of this debilitating disease that affects four million Americans and their families.
We are researching several promising new ways of treating dementia, an illness that is desperately in need of new treatments.
A research study testing the effectiveness of an investigational medication for treating agitation from Alzheimer’s Disease is now underway at Richmond Behavioral Associates in Staten Island.
Study Participants Will Receive
- All study-related evaluations, physical exams and visits at no cost
- All study medication at no cost
- Possible compensation for study-related time and travel
Complete this short survey to see if you qualify
Please tell us about yourself so that we can reach out about clinical trial opportunities. All the information you complete will remain private.
